Predicted to act upstream of or within negative regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. Predicted to be active in cytoskeleton. Orthologous to human TAGLN3 (transgelin 3). [provided by Alliance of Genome Resources, Apr 2022]